Myomo® Announces New Distribution Agreement for Australia / New Zealand
CAMBRIDGE, Mass., May 1, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with NeuroMuscular Orthotics Pty Ltd (NMO) with the goal of offering MyoPro across […]
Myomo® Announces New Sales and Service Agreement for Chile
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with Tecnoplanta Orthopedic Laboratory with the goal of offering MyoPro in Chile. Read more.
Myomo® Announces New Sales and Service Agreement for Italy
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with Progettiamo Autonomia Robotics (PAR) with the goal of offering MyoPro in Italy. PAR is a unit of […]
Myomo Makes NYSE American Section 610(b) Public Announcement
CAMBRIDGE, Mass., March 15, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2018 filed […]
Kessler Foundation Awarded Grant to Study Wearable Robotic in Spinal Cord Injury
East Hanover, NJ – March 12, 2018 – Ghaith J. Androwis, PhD, research scientist in the Center for Mobility and Engineering Rehabilitation Research at Kessler Foundation, has been awarded a $500,000 grant from the Department of Defense (DOD), Congressionally Directed Medical Research Programs (CDMRP). The award funds a three-year study titled, “Efficacy of Wearable Robotic […]
Myomo Announces Participation at Two Upcoming Investor Conferences
CAMBRIDGE, Mass.–(BUSINESS WIRE)– Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that Chairman and Chief Executive Officer Paul R. Gudonis and Chief Financial Officer David Henry will be presenting, as well as meeting […]
Myomo Reports Fourth Quarter and Year End 2018 Results
CAMBRIDGE, Mass., March 7, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced its financial results for the fourth quarter and year ended December 31, 2018. Read more.
Myomo Reports Fourth Quarter Year End 2018 Results
CAMBRIDGE, Mass., February 28, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2018 on Thursday, […]
Myomo, Inc. Announces Closing of Public Offering and Full Exercise of Over-Allotment Option
CAMBRIDGE, Mass., February 12, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today has closed its previously announced underwritten public offering of 3,950,000 shares of common stock at an offering price of $1.40 […]
Myomo, Inc. Prices Public Offering of Common Stock
CAMBRIDGE, Mass., February 8, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced the pricing of its previously announced underwritten public offering of 3,950,000 shares of its common stock at an offering […]